For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Scope of the Report:
This report focuses on the 10-Deacetylbaccatin III in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
As new companies enter the market for finished paclitaxel, bulk demand will increase as competition forces down prices, the study notes, adding that, with the drug becoming more affordable, physicians are expected to prescribe it more freely. However, while demand may be rising, paclitaxel is derived from a natural resource, and its long-term availability is in question.
Yew trees are slow-growing, and the extraction process requires numerous trees to supply an adequate amount, it says. The possible scarcity of the product is spurring sales, especially to the research sector where large stocks are necessary for proper experimentation. However, the report notes that enterprising companies have found ways to circumvent this issue and increase supply.
With advances in technology, new and better ways of extracting paclitaxel have evolved, with plant cell culture techniques and genetic engineering also emerging as fruitful methods of enhancing production says F&S. These methods have resulted in ample and continuous supplies, which is expected to boost the quantities of bulk paclitaxel, and subsequently augment the revenues generated by finished products, the report adds.
The worldwide market for 10-Deacetylbaccatin III is expected to grow at a CAGR of roughly 4.3% over the next five years, will reach 74 million US$ in 2023, from 58 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- SM Herbals
- Alchem International
- South Pharmaceutical
- Yuannan Hande
- Sai Phytoceuticals
- Sarv Biolabs Pvt
- Hainan Yew Pharmaceutical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Production of Docetaxel
- Production of Paclitaxel
There are 15 Chapters to deeply display the global 10-Deacetylbaccatin III market.
Chapter 1, to describe 10-Deacetylbaccatin III Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of 10-Deacetylbaccatin III, with sales, revenue, and price of 10-Deacetylbaccatin III, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of 10-Deacetylbaccatin III, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, 10-Deacetylbaccatin III market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe 10-Deacetylbaccatin III sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source